Lisa Ricciardi - 15 Nov 2022 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role: CEO & President, Director
Signature: Lisa Ricciardi
Issuer symbol: CGTX
Transactions as of: 15 Nov 2022
Net transactions value: +$15,600
Form type: 4
Filing time: 16 Nov 2022, 07:31:02 UTC
Previous filing: 23 Jun 2022
Next filing: 07 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CGTX	Common Stock	Purchase	$15,600	+12,000	+96%	$1.30	24,500	15 Nov 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average purchase price of $1.297. These shares were acquired in multiple transactions ranging from $1.285 to $1.300 rounded to the nearest thousandth. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission, Cognition Therapeutics, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Represents the weighted average purchase price of $1.297. These shares were acquired in multiple transactions ranging from $1.285 to $1.300 rounded to the nearest thousandth. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission, Cognition Therapeutics, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.